BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1954 related articles for article (PubMed ID: 15919414)

  • 21. Developmental and functional analyses of CD8(+) NK1.1(+) T cells in class-I-restricted TCR transgenic mice.
    Ohwatari R; Iwabuchi K; Iwabuchi C; Morohashi T; Sawa H; Hioki K; Kobayashi K; Fukuda S; Inuyama Y; Onoé K
    Cell Immunol; 2001 Oct; 213(1):24-33. PubMed ID: 11747353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. De novo-developed T cells have compromised response to existing alloantigens: using Ld-specific transgenic 2C T cells as tracers in a mouse heart transplantation model.
    Luo H; Chen H; Qi S; Loh D; Daloze P; Veillette A; Xu D; Wu J
    J Immunol; 1998 Jul; 161(1):73-82. PubMed ID: 9647209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4+ T-cell-independent rejection of corneal allografts.
    Niederkorn JY; Stevens C; Mellon J; Mayhew E
    Transplantation; 2006 Apr; 81(8):1171-8. PubMed ID: 16641604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
    Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta}.
    Cheng ML; Chen HW; Tsai JP; Lee YP; Shih YC; Chang CM; Ting CC
    J Leukoc Biol; 2006 May; 79(5):1033-42. PubMed ID: 16478921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4-negative cytotoxic T cells with a T cell receptor alpha/beta intermediate expression in CD8-deficient mice.
    Dalloul AH; Ngo K; Fung-Leung WP
    Eur J Immunol; 1996 Jan; 26(1):213-8. PubMed ID: 8566069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Class I- and class II-reactive TCRs coexpressed on CD4+ T cells both trigger CD4/CD8-shared and CD4-unique functions.
    Asnagli H; Schmitt-Verhulst AM; Guimezanes A
    J Immunol; 1997 May; 158(10):4533-42. PubMed ID: 9144464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early regulation of CD8 T cell alloreactivity by CD4+CD25- T cells in recipients of anti-CD154 antibody and allogeneic BMT is followed by rapid peripheral deletion of donor-reactive CD8+ T cells, precluding a role for sustained regulation.
    Fehr T; Takeuchi Y; Kurtz J; Wekerle T; Sykes M
    Eur J Immunol; 2005 Sep; 35(9):2679-90. PubMed ID: 16082727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occurrence of interleukin-5 production by CD4- CD8- (double-negative) T cells in lungs of both normal and congenitally athymic nude mice infected with Toxocara canis.
    Takamoto M; Kusama Y; Takatsu K; Nariuchi H; Sugane K
    Immunology; 1995 Jun; 85(2):285-91. PubMed ID: 7642218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positive and negative selection of an antigen receptor on T cells in transgenic mice.
    Sha WC; Nelson CA; Newberry RD; Kranz DM; Russell JH; Loh DY
    Nature; 1988 Nov; 336(6194):73-6. PubMed ID: 3263574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
    Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR
    J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
    Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL
    Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral deletion of mature CD8+ antigen-specific T cells after in vivo exposure to male antigen.
    Zhang LI; Martin DR; Fung-Leung WP; Teh HS; Miller RG
    J Immunol; 1992 Jun; 148(12):3740-5. PubMed ID: 1534823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.
    Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W
    J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of NK1+ CD4- CD8- alphabeta T cells and endogenous IL-4 in non-MHC-restricted rejection of embryonal carcinoma in genetically resistant mice.
    Nakamura E; Kubota H; Sato M; Sugie T; Yoshida O; Minato N
    J Immunol; 1997 Jun; 158(11):5338-48. PubMed ID: 9164954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic and functional analysis of murine CD3+,CD4-,CD8- TCR-gamma delta-expressing peripheral T cells.
    Cron RQ; Gajewski TF; Sharrow SO; Fitch FW; Matis LA; Bluestone JA
    J Immunol; 1989 Jun; 142(11):3754-62. PubMed ID: 2523934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression.
    Huang H; Li F; Gordon JR; Xiang J
    Cancer Res; 2002 Apr; 62(7):2043-51. PubMed ID: 11929823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-7 promotes thymocyte proliferation and maintains immunocompetent thymocytes bearing alpha beta or gamma delta T-cell receptors in vitro: synergism with IL-2.
    Okazaki H; Ito M; Sudo T; Hattori M; Kano S; Katsura Y; Minato N
    J Immunol; 1989 Nov; 143(9):2917-22. PubMed ID: 2572646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunological function of HLA-DQw6 molecules expressed in DQw6 transgenic C57BL/6 mice].
    Inamitsu T
    Fukuoka Igaku Zasshi; 1991 Feb; 82(2):59-70. PubMed ID: 2022362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
    Muraoka S
    Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 98.